Amphastar Pharmaceuticals, Inc.

AMPHNASDAQHealthcare● Active

$19.47

$-0.27(-1.37%)

Market Cap$858489133

P/E Ratio—

52W High$31.26

52W Low$16.65

Avg Volume610K

Open$19.75

Beta0.90

Net Income Financials Revenue

Amphastar Pharmaceuticals, Inc. (AMPH) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

AMPH · net income · updated Jun 8, 2026

Core profitability metrics

AMPH · net income · margin · TTM · CAGR

Net income was $98.1M for FY2025 (fiscal year ending 2025-12-31), down 38.5% year-over-year. Net profit margin was 13.6%. Based on available data, Amphastar Pharmaceuticals, Inc. has been profitable since at least 2011.

FY2025 Net Income$98.1M▼ -38.5% YoY

Trailing 12M (TTM)$79.2Mtrailing 4 quarters sum

Net Profit Margin13.6%$98.1M ÷ $719.9M

YoY Change-38.5%—

5-Year CAGR+133.8%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · AMPH net income history · AMPH profit margin

Annual net income data

AMPH · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$98.1M▼ 38.5%13.6%$719.9M

FY2024$159.5M▲ +16.0%21.8%$732.0M

FY2023$137.5M▲ +50.5%21.3%$644.4M

FY2022$91.4M▲ +47.1%18.3%$499.0M

FY2021$62.1M▲ +4327.4%14.2%$437.8M

Net income vs peers (Healthcare)

AMPH vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Amphastar Pharmaceuticals, Inc.YOU

AMPH

$98.1M-38.5%13.6%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Amphastar Pharmaceuticals, Inc. (AMPH) reported net income of $98.1M for FY2025 (fiscal year ending 2025-12-31), down 38.5% year-over-year. The net profit margin was 13.6% — meaning the company kept $0.14 of every dollar of revenue as profit.

Based on available data, Amphastar Pharmaceuticals, Inc. has been profitable since at least 2011. Net income reached a peak of $159.5M in FY2024. Data available for 15 fiscal years.

Amphastar Pharmaceuticals, Inc.'s net profit margin was 13.6% for FY2025, based on the latest annual results.

Investors sometimes search for "Amphastar Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from AMPH net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

AMPH net income · 5 questions

Amphastar Pharmaceuticals, Inc. is profitable. The company reported net income of $98.1M for FY2025, a net profit margin of 13.6%. Net income was down 38.5% year-over-year. Based on available data, Amphastar Pharmaceuticals, Inc. has been profitable since at least 2011.

is AMPH profitabledoes AMPH make a profitAMPH profitabilityAMPH profitable company

▸ Source: FMP /income-statement · GAAP · Amphastar Pharmaceuticals, Inc. · Amphastar Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026